These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22232061)

  • 1. A direct method and ICER tables for the estimation of the cost-effectiveness of smoking cessation interventions in general populations: application to a new cytisine trial and other examples.
    Stapleton JA; West R
    Nicotine Tob Res; 2012 Apr; 14(4):463-71. PubMed ID: 22232061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
    Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
    Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are financial incentives cost-effective to support smoking cessation during pregnancy?
    Boyd KA; Briggs AH; Bauld L; Sinclair L; Tappin D
    Addiction; 2016 Feb; 111(2):360-70. PubMed ID: 26370095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Cost-Effectiveness of Smoking Cessation Interventions in People With Mental Disorders: A Dynamic Decision Analytical Model.
    Wu Q; Gilbody S; Li J; Wang HI; Parrott S
    Value Health; 2021 Sep; 24(9):1263-1272. PubMed ID: 34452705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial.
    Thomas D; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn CP; Hall W; Paul C; Zwar N; Ferguson SG; Boland VC; Richmond R; Doran CM; Shakeshaft A; Mattick RP; Courtney RJ
    Addiction; 2019 May; 114(5):923-933. PubMed ID: 30589984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.
    Mundt MP; Baker TB; Fraser DL; Smith SS; Piper ME; Fiore MC
    Value Health; 2019 Feb; 22(2):177-184. PubMed ID: 30711062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students.
    Popp J; Nyman JA; Luo X; Bengtson J; Lust K; An L; Ahluwalia JS; Thomas JL
    Eur J Health Econ; 2018 Dec; 19(9):1319-1333. PubMed ID: 29687268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    Keating GM; Lyseng-Williamson KA
    Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
    Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
    Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.
    Cantor SB; Deshmukh AA; Luca NS; Nogueras-González GM; Rajan T; Prokhorov AV
    Addict Behav; 2015 Jun; 45():79-86. PubMed ID: 25644592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cost-Effectiveness Analysis of Stop Smoking Interventions in Substance-Use Disorder Populations.
    Healey A; Roberts S; Sevdalis N; Goulding L; Wilson S; Shaw K; Jolley C; Robson D
    Nicotine Tob Res; 2019 Apr; 21(5):623-630. PubMed ID: 29733376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP).
    Essex HN; Parrott S; Wu Q; Li J; Cooper S; Coleman T
    Nicotine Tob Res; 2015 Jun; 17(6):636-42. PubMed ID: 25481916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
    Taylor M; Leonardi-Bee J; Agboola S; McNeill A; Coleman T
    Addiction; 2011 Oct; 106(10):1819-26. PubMed ID: 21561499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
    Coleman T; Agboola S; Leonardi-Bee J; Taylor M; McEwen A; McNeill A
    Health Technol Assess; 2010 Oct; 14(49):1-152, iii-iv. PubMed ID: 21040645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care.
    Smith MY; Cromwell J; DePue J; Spring B; Redd W; Unrod M
    Manag Care; 2007 Jul; 16(7):48-55. PubMed ID: 17907712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.